What 21 Years Of Data Reveals About Chronic Disease Prevention

Nurse showing a patient health data on a tablet

A single lifestyle intervention started in the late 1990s is still protecting people from chronic disease more than two decades later, and the pill everyone expected to match it simply did not.

Story Snapshot

A 21-year study found that adults with prediabetes who did an intensive lifestyle program had a 21% lower risk of developing two or more chronic diseases compared to a placebo group.
The drug metformin showed no meaningful reduction in that same chronic disease risk over the same period.
The lifestyle benefit held even when researchers removed diabetes from the equation entirely, proving the effect goes far beyond just blood sugar.
85% of all study participants eventually developed at least two chronic conditions, showing how high the stakes are for anyone with prediabetes.

The Study That Followed People for Over Two Decades

The Diabetes Prevention Program (DPP) launched in the mid-1990s with a simple question: can you stop prediabetes from turning into type 2 diabetes? Researchers enrolled 3,234 adults with prediabetes and split them into three groups. One group made intensive lifestyle changes. One group took metformin, a common diabetes drug. One group got a placebo. The original trial ran about three years. But then researchers kept following the participants, and kept following them, for over 21 years total.

The lifestyle program was not complicated or exotic. It focused on modest weight loss, around 7% of body weight, and 150 minutes of moderate physical activity per week. No surgery. No expensive drugs. Just consistent, disciplined behavior change. After the first three years, that approach cut the rate of new diabetes diagnoses by 58% compared to placebo. Metformin cut it by 31%. Those early numbers made headlines. What happened next is the real story.

What 21 Years of Data Actually Reveals

A June 2026 analysis published in JAMA looked at something researchers had not fully examined before: did the lifestyle intervention reduce the overall burden of multiple chronic diseases, not just diabetes? The answer was yes. Participants in the lifestyle group had a 21% lower risk of developing multimorbidity, defined as two or more chronic conditions, compared to the placebo group. ^[1] The conditions tracked included hypertension, heart disease, stroke, arthritis, chronic kidney disease, chronic obstructive pulmonary disease, cancer, depression, and dementia, among others.

The finding that should stop you cold is this: the risk reduction held even when researchers took diabetes completely out of the definition of multimorbidity. That means the lifestyle intervention protected people against a whole cluster of serious diseases beyond just blood sugar problems. For the costliest disease combinations, including stroke, chronic kidney disease, heart failure, and chronic obstructive pulmonary disease together, the risk reduction was even sharper, with a hazard ratio of 0.57 compared to placebo. ^[1] In plain terms, the lifestyle group was nearly half as likely to develop those devastating combinations.

The Honest Complications in the Data

The full picture is not a clean triumph. Researchers also found that neither the lifestyle intervention nor metformin reduced major cardiovascular events like heart attacks or stroke as standalone outcomes over 21 years. ^[6] That is a meaningful limitation. The DPP’s long-term outcomes study confirms it directly: despite successfully preventing diabetes, neither intervention moved the needle on major cardiovascular events or cancer incidence over the long term. ^[2] Science rarely gives you everything, and this study is no exception.

However, there is a critical distinction worth making. People in the study who never developed diabetes at all had a 39% lower risk of major cardiovascular events compared to those who did develop it. ^[3] The intervention did not directly prevent heart attacks, but preventing diabetes itself appears to be a powerful shield against them. That is not a contradiction. It is a reminder that the path to better heart health may run directly through metabolic health first. The lifestyle group also showed a long-term reduction in frailty, which matters enormously for quality of life in older age.

What This Means If You Have Prediabetes Right Now

Roughly 98 million American adults have prediabetes, and most do not know it. The DPP data makes clear that prediabetes is not a minor warning sign to address someday. It is an open window with a closing timeline. The lifestyle intervention in the study extended diabetes-free survival by 3.5 years per person compared to placebo. ^[5] Metformin extended it by 2.5 years. But only the lifestyle approach reduced the broader chronic disease burden. The drug did not. That gap deserves serious attention from anyone who believes personal responsibility and behavioral choices are the foundation of long-term health.

Moving your body, eating with discipline, and losing even a modest amount of weight does something a pill cannot replicate. It changes the trajectory of aging itself. The DPP evidence now shows that a structured lifestyle change in midlife can reduce the likelihood of spending your later years managing two, three, or four serious chronic conditions at once. That is not a small finding. It is one of the most important public health results of the past generation, and it deserves far more attention than it gets.